Izumikawa K - Search Results

1

Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan.

Tashiro M, Izumikawa K, Minematsu A, Hirano K, Iwanaga N, Ide S, Mihara T, Hosogaya N, Takazono T, Morinaga Y, Nakamura S, Kurihara S, Imamura Y, Miyazaki T, Nishino T, Tsukamoto M, Kakeya H, Yamamoto Y, Yanagihara K, Yasuoka A, Tashiro T, Kohno S. Tashiro M, et al. Among authors: izumikawa k. Antimicrob Agents Chemother. 2012 Jan;56(1):584-7. doi: 10.1128/AAC.05394-11. Epub 2011 Oct 24. Antimicrob Agents Chemother. 2012. PMID: 22024829 Free PMC article.

2

In vitro activities of quinupristin-dalfopristin and the streptogramin RPR 106972 against Mycoplasma pneumoniae.

Izumikawa K, Hirakata Y, Yamaguchi T, Yoshida R, Tanaka H, Takemura H, Maesaki S, Tomono K, Kaku M, Izumikawa KI, Kamihira S, Kohno S. Izumikawa K, et al. Among authors: izumikawa ki. Antimicrob Agents Chemother. 1998 Mar;42(3):698-9. doi: 10.1128/AAC.42.3.698. Antimicrob Agents Chemother. 1998. PMID: 9517955 Free PMC article.

3

Prolonged survival of mice with Pseudomonas aeruginosa-induced sepsis by rIL-12 modulation of IL-10 and interferon-gamma.

Yamaguchi T, Hirakata Y, Izumikawa K, Miyazaki Y, Maesaki S, Tomono K, Yamada Y, Kohno S, Kamihira S. Yamaguchi T, et al. Among authors: izumikawa k. J Med Microbiol. 2000 Aug;49(8):701-707. doi: 10.1099/0022-1317-49-8-701. J Med Microbiol. 2000. PMID: 10933254

4

[A successful treatment of Vibrio vulnificus infection].

Sasaki E, Yamanouchi H, Shioshita K, Hayakawa T, Izumikawa K, Izumikawa K, Hara K, Hirakata Y, Kohno S. Sasaki E, et al. Among authors: izumikawa k. Kansenshogaku Zasshi. 2002 May;76(5):391-5. doi: 10.11150/kansenshogakuzasshi1970.76.391. Kansenshogaku Zasshi. 2002. PMID: 12073576 Japanese.

5

Clinical and bacteriological characteristics of IMP-type metallo-beta-lactamase-producing Pseudomonas aeruginosa.

Hirakata Y, Yamaguchi T, Nakano M, Izumikawa K, Mine M, Aoki S, Kondoh A, Matsuda J, Hirayama M, Yanagihara K, Miyazaki Y, Tomono K, Yamada Y, Kamihira S, Kohno S. Hirakata Y, et al. Among authors: izumikawa k. Clin Infect Dis. 2003 Jul 1;37(1):26-32. doi: 10.1086/375594. Epub 2003 Jun 24. Clin Infect Dis. 2003. PMID: 12830405

6

Azithromycin exhibits bactericidal effects on Pseudomonas aeruginosa through interaction with the outer membrane.

Imamura Y, Higashiyama Y, Tomono K, Izumikawa K, Yanagihara K, Ohno H, Miyazaki Y, Hirakata Y, Mizuta Y, Kadota J, Iglewski BH, Kohno S. Imamura Y, et al. Among authors: izumikawa k. Antimicrob Agents Chemother. 2005 Apr;49(4):1377-80. doi: 10.1128/AAC.49.4.1377-1380.2005. Antimicrob Agents Chemother. 2005. PMID: 15793115 Free PMC article.

7

Fluconazole treatment is effective against a Candida albicans erg3/erg3 mutant in vivo despite in vitro resistance.

Miyazaki T, Miyazaki Y, Izumikawa K, Kakeya H, Miyakoshi S, Bennett JE, Kohno S. Miyazaki T, et al. Among authors: izumikawa k. Antimicrob Agents Chemother. 2006 Feb;50(2):580-6. doi: 10.1128/AAC.50.2.580-586.2006. Antimicrob Agents Chemother. 2006. PMID: 16436713 Free PMC article.

8

A case of Mycobacterium nonchromogenicum pulmonary infection showing multiple nodular shadows in an immunocompetent patient.

Sawai T, Inoue Y, Doi S, Izumikawa K, Ohno H, Yanagihara K, Higashiyama Y, Miyazaki Y, Hirakata Y, Tashiro T, Kohno S. Sawai T, et al. Among authors: izumikawa k. Diagn Microbiol Infect Dis. 2006 Apr;54(4):311-4. doi: 10.1016/j.diagmicrobio.2005.11.005. Epub 2006 Feb 8. Diagn Microbiol Infect Dis. 2006. PMID: 16466887

9

Potency of DX-619, a novel des-F(6)-quinolone, in haematogenous murine bronchopneumonia caused by methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.

Yanagihara K, Seki M, Izumikawa K, Higashiyama Y, Miyazaki Y, Hirakata Y, Tomono K, Mizuta Y, Tsukamoto K, Kohno S. Yanagihara K, et al. Among authors: izumikawa k. Int J Antimicrob Agents. 2006 Sep;28(3):212-6. doi: 10.1016/j.ijantimicag.2006.03.026. Epub 2006 Aug 2. Int J Antimicrob Agents. 2006. PMID: 16887340

10

Clinical comparative study of sulbactam/ampicillin and imipenem/cilastatin in elderly patients with community-acquired pneumonia.

Yanagihara K, Fukuda Y, Seki M, Izumikawa K, Higashiyama Y, Miyazaki Y, Hirakata Y, Tomono K, Mizuta Y, Tsukamoto K, Kohno S. Yanagihara K, et al. Among authors: izumikawa k. Intern Med. 2006;45(17):995-9. doi: 10.2169/internalmedicine.45.1717. Epub 2006 Oct 2. Intern Med. 2006. PMID: 17015999 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

484 results

Search Page

Filters